BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers

The BNT162b2 vaccine, containing lipid nanoparticles-formulated mRNA encoding the full-length spike protein of SARS-CoV-2, has been employed to immunize health care workers in Italy, administered in two doses 21 days apart. In this study, we characterized the antibody response induced by the BNT162b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratesi, Federico, Caruso, Teresita, Testa, Davide, Tarpanelli, Tiziano, Gentili, Alessandra, Gioè, Davide, Migliorini, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234791/
https://www.ncbi.nlm.nih.gov/pubmed/34207300
http://dx.doi.org/10.3390/vaccines9060672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234791/
https://www.ncbi.nlm.nih.gov/pubmed/34207300
http://dx.doi.org/10.3390/vaccines9060672

Ejemplares similares